With the number of COVID-19 cases rising due to the Delta variant, Diagnostic Laboratory of Oklahoma (DLO) is now offering drive-thru COVID-19 molecular laboratory (PCR/NAAT) and rapid antigen testing at no cost to patients at its corporate headquarters located at 225 NE 97th Street in Oklahoma City. The drive-thru hours are Monday through Friday from 7 a.m. to 6 p.m. and on Saturday from 8 a.m. to 4 p.m. with no doctor’s order required. The turnaround time for PCR test results is 1-2 days, while the rapid antigen test results are typically reported in under an hour.
Appointments are required and DLO has numerous apppointment times available throughout the day. In order to maintain an efficient process to best serve our patients, drive-up patients will not be accepted.
“As the demand for testing increased, DLO recognized a need for efficient collection and testing in our community,” said R’Nee Mullen, DLO Chief Executive Officer. “By collecting specimens at our Central Laboratory, which is conveniently located off Broadway Extension and Britton Road, we remove the delay for specimen transportation and can quickly start the testing process, creating faster test results for our patients.”
Adults can request access to the company's $0 out-of-pocket COVID-19 test option for themselves and children 2 years of age and older through QuestDirect™, the company's online consumer-initiated test platform. Eligibility for $0 out-of-pocket COVID-19 testing includes adults and minors who are U.S. citizens with a valid driver’s license or social security number, regardless of symptoms or suspected exposure, consistent with updated government guidance on insurance coverage for COVID-19 testing. For patients with insurance, the test will be billed to their commercial health plan, while government payors will cover the cost of testing for uninsured patients.
“Whether you have been exposed to someone with COVID-19, need testing for travel or entry into events, or just want peace of mind, DLO is pleased to provide access to testing at no cost to the patient,” said Mullen.
While the $0 out-of-pocket option applies to PCR and rapid antigen testing, DLO also offers the ability to purchase COVID-19 antibody testing through QuestDirect without needing a doctor’s visit. DLO offers QuestDirect to Oklahoma through a joint venture partnership with Quest Diagnostics, the world's leading provider of diagnostic information services.
Diagnostic Laboratory of Oklahoma (DLO) today unveiled several new enhancements to its COVID-19 testing services, with the goal to help combat COVID-19 while empowering more individuals and families to resume "back to life" activities with greater safety this spring, summer and beyond.
Starting today, adults can request access to the company's $0 out-of-pocket COVID-19 test option for themselves and children 4 years of age and older through QuestDirect™, the company's online consumer-initiated test platform. Eligibility for $0 out-of-pocket COVID-19 testing includes adults and minors regardless of symptoms or suspected exposure, consistent with updated government guidance on insurance coverage for COVID-19 testing. The $0 out-of-pocket option applies to molecular laboratory (PCR/NAAT).
An individual simply fills out a form online, which is quickly reviewed by an independent physician. If deemed eligible by the physician, the individual may then schedule an appointment for an observed self-collection at a DLO Patient Service Center (asymptomatic patients) or at select Walmart Neighborhood Market Pharmacy locations (symptomatic patients) throughout Oklahoma. Same-day appointments may be available, with test results typically provided the next day. The $0 out-of-pocket COVID-19 test option through QuestDirect is not available for asymptomatic individuals without known or suspected exposure for public health surveillance or employment purposes.
DLO offers QuestDirect to Oklahoma through a joint venture partnership with Quest Diagnostics, the world's leading provider of diagnostic information services. Quest is believed to be the first national laboratory provider to enable a patient to request access to COVID-19 diagnostic testing, regardless of symptoms or exposure, through a consumer-initiated testing site with broadly accessible observed self-collection at no cost to individuals. The test will be billed to commercial health plans and government payors. The expanded test option comes as governments and organizations seek ways to utilize testing to resume safer in-person customer interactions.
For more information or to check eligibility for testing, visit dlolab.com/questdirect.
As of April 20, Diagnostic Laboratory of Oklahoma (DLO) has tested 8,268 patients for COVID-19 through a combination of in-house lab testing and through Quest Diagnostics, a joint venture partner for DLO. In addition to the molecular PCR swab testing for those with symptoms of an active infection, DLO is now offering a COVID-19 SARS-CoV-2 immunoglobulin G (IgG) antibody serology test which can identify individuals who have developed a serological response.
DLO began offering COVID-19 PCR testing through Quest Diagnostics on March 9 to support the pandemic, and then began in-house PCR testing on March 28 in two of its Oklahoma City laboratories. DLO’s in-house PCR testing attention is on Priority 1 and Priority 2 testing as recommended by the US Department of Health and Human Services (HHS). All other PCR testing done by DLO is completed through a Quest Diagnostics lab.
"Our lab staff worked tirelessly to go through the processes needed to bring critical COVID-19 testing to our Oklahoma-based labs in record time,” said DLO CEO Dennis Hogle. “By concentrating on at-risk hospital patients and healthcare workers with COVID-19 symptoms, DLO can accelerate the results and give providers the opportunity to quickly create a plan of action for treatment. With the addition of IgG serology testing, DLO can now provide added focus on identifying Oklahomans who have been exposed and recovered from COVID-19.”
DLO continues to work with hospital leadership across the state to offer access to these vital tests to maintain the integrity of Oklahoma’s healthcare systems. To further expand testing, DLO is working to add immunoglobulin M (IgM) antibody testing soon.
“As an Oklahoma-based company, DLO’s focus is to provide innovative, timely and quality laboratory services to the citizens of our state,” said Hogle. “DLO will continue our efforts to expand our COVID-19 testing through IgM antibody tests in the near future, but we are pleased to be able to provide critical Priority 1, Priority 2 and IgG antibody testing to Oklahoma.”
DLO has 45 patient service centers throughout Oklahoma and provides clinical laboratory testing for all 77 counties in Oklahoma. Hogle said it’s important the public use their healthcare providers for COVID-19 PCR swab specimen collections, but the IgG serology test is a routine blood collection and can be drawn at a DLO location with a provider’s order.
“Our patient service centers do an excellent job of collecting specimens for blood and urine testing, so we are able to collect samples for the IgG serology tests at our locations throughout Oklahoma,” said Hogle. “However, the COVID-19 PCR swab test is for symptomatic patients and is to be performed only using respiratory specimens collected by a healthcare provider from individuals who meet CDC clinical and/or epidemiological criteria for COVID-19 testing. Our DLO Patient Service Centers do not collect COVID-19 PCR swab specimens for symptomatic patients suspected of having an active COVID-19 infection.”
DLO has also instituted additional precautions for patients who use their facilities for routine lab testing.
“DLO wants to do all we can to protect our patients and employees from exposure to any illness,” said Hogle. “We have implemented additional steps to make our patient service centers safer including limiting the number of chairs in the waiting areas to maintain social distancing and taking patients back to draw rooms to wait until we can collect their specimen. We are also asking all patients to wear masks when visiting DLO, and unless you need a caregiver, we ask that only patients enter the PSC. We also encourage our patients to schedule an appointment through our website to help further reduce any wait time.”
For more information on DLO’s response to COVID-19, visit dlolab.com/covid-19.
Diagnostic Laboratory of Oklahoma (DLO) began offering COVID-19 testing in Oklahoma on March 9 through Quest Diagnostics. As a joint venture of Quest Diagnostics and INTEGRIS Health, DLO is utilizing Quest’s laboratories in Dallas, Texas and San Juan Capistrano, Calif. DLO is now in the process of expanding its efforts by bringing up its own COVID-19 testing at its central laboratory in Oklahoma City to deliver more testing capacity to the state of Oklahoma.
“DLO employs 700 of the finest employees in Oklahoma and they are all working hard and are involved in taking the necessary measure to keep DLO safe and healthy, so we can continue to provide vital laboratory testing services to all parts of Oklahoma,” said DLO CEO Dennis Hogle.
Last week, DLO and the Oklahoma State Department of Health (OSDH) announced a public-private partnership to send some OSDH tests to DLO for processing to meet the high demand. Nearly 500 test specimens were shipped to Quest’s Dallas lab on the first day of the partnership and additional tests are being sent daily.
“As an Oklahoma-based company, DLO is pleased to partner with OSDH to serve Oklahomans during this crisis,” said Hogle. “As DLO and Quest continue expanding our COVID-19 testing efforts, we are in a position to provide quality lab tests and improve the turnaround time for results.”
While DLO has 45 patient service centers throughout Oklahoma and provides clinical laboratory testing for all 77 counties in Oklahoma, Hogle said it’s important the public use their healthcare providers for COVID-19 specimen collections.
“Our patient service centers do an excellent job of collecting specimens for testing,” said Hogle. “However, this test is to be performed only using respiratory specimens collected from individuals who meet CDC clinical and/or epidemiological criteria for COVID-19 testing, and only a healthcare provider can collect the specimen necessary to test for COVID-19. Our DLO Patient Service Centers do not collect COVID-19 specimens and patients suspected of having COVID-19 must not enter a DLO Patient Service Center.”
For more information on DLO’s response to COVID-19, visit dlolab.com/covid-19.
The Oklahoma State Department of Health (OSDH) today announced it has entered into a new public-private partnership with Diagnostic Laboratory of Oklahoma (DLO) to increase the State of Oklahoma’s capacity for delivering results for COVID-19 tests. As a result of the new partnership, more than 300 test specimens were immediately shipped yesterday to DLO’s facility in Dallas, Texas, for results within the next couple days.
“The Oklahoma State Department of Health appreciates the strengthened partnership with DLO to send COVID-19 test kits to its facilities in Dallas for rapid results,” said Commissioner of Health Gary Cox. “The state is committed to expanding testing and result capacity by building out more public-private partnerships here at home and across the United States. Thanks to action taken at the federal level, we are expecting more supplies to come online in the coming days to support our efforts."
The state’s partnership with DLO will allow current demand for COVID-19 test results to be met within a two- to three-day time frame. The Public Health Laboratory will continue to prioritize its limited in-house supply for delivering results within 24-hours for Oklahoma’s most vulnerable populations. Vulnerable populations are identified as follows:
- Where a cluster of individuals are experiencing COVID-19 symptoms, such as a nursing home
- Individuals who are age 60 or older
- Children or adults who have compromised immune systems
“As this new public-private lab partnership expands Oklahoma’s capacity to deliver timely results, it will allow the OSDH, county health departments, hospitals, health care providers and others begin pursuing innovative options for increasing access to COVID-19 testing,” Cox said.
For more information about COVID-19, visit coronavirus.health.ok.gov.